These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27931297)

  • 1. Chronic obstructive pulmonary disease phenotypes, biomarkers, and prognostic indicators.
    Brightling CE
    Allergy Asthma Proc; 2016 Nov; 37(6):432-438. PubMed ID: 27931297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.".
    Corlateanu A; Mendez Y; Wang Y; Garnica RJA; Botnaru V; Siafakas N
    Pulmonology; 2020; 26(2):95-100. PubMed ID: 31740261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease.
    Van Tho N; Ogawa E; Trang le TH; Ryujin Y; Kanda R; Nakagawa H; Goto K; Fukunaga K; Higami Y; Seto R; Wada H; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
    Ann Am Thorac Soc; 2015 Jul; 12(7):988-96. PubMed ID: 25844673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease in a new concept.
    Murărescu ED; Mitrofan EC; Mihailovici MS
    Rom J Morphol Embryol; 2007; 48(3):207-14. PubMed ID: 17914487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical approaches towards asthma and chronic obstructive pulmonary disease based on the heterogeneity of disease pathogenesis.
    Hizawa N
    Clin Exp Allergy; 2016 May; 46(5):678-87. PubMed ID: 27009427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recent advances of phenotypes in acute exacerbations of COPD.
    Zhou A; Zhou Z; Zhao Y; Chen P
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1009-1018. PubMed ID: 28392685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotyping the heterogeneity of chronic obstructive pulmonary disease.
    Barker BL; Brightling CE
    Clin Sci (Lond); 2013 Mar; 124(6):371-87. PubMed ID: 23190267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1.
    Coxson HO; Leipsic J; Parraga G; Sin DD
    Am J Respir Crit Care Med; 2014 Jul; 190(2):135-44. PubMed ID: 24873985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypes and disease characterization in chronic obstructive pulmonary disease. Toward the extinction of phenotypes?
    Agustí A
    Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S125-30. PubMed ID: 24313762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in Chronic Obstructive Pulmonary Disease.
    Wen L; Krauss-Etschmann S; Petersen F; Yu X
    Front Immunol; 2018; 9():66. PubMed ID: 29422903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.
    Sand JM; Leeming DJ; Byrjalsen I; Bihlet AR; Lange P; Tal-Singer R; Miller BE; Karsdal MA; Vestbo J
    Respir Res; 2016 Oct; 17(1):125. PubMed ID: 27716343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease.
    Lopez-Campos JL; Calero-Acuña C; Lopez-Ramirez C; Abad-Arranz M; Márquez-Martín E; Ortega-Ruiz F; Arellano E
    Biomark Med; 2016; 10(2):109-22. PubMed ID: 26808692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should we define and classify exacerbations in chronic obstructive pulmonary disease?
    Trigueros Carrero JA
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):33-41. PubMed ID: 23551022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advances.
    Carolan BJ; Sutherland ER
    J Allergy Clin Immunol; 2013 Mar; 131(3):627-34; quiz 635. PubMed ID: 23360757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What does endotyping mean for treatment in chronic obstructive pulmonary disease?
    Agustí A; Celli B; Faner R
    Lancet; 2017 Sep; 390(10098):980-987. PubMed ID: 28872030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phenotypes of obstructive airway diseases in an outpatient population.
    Rootmensen G; van Keimpema A; Zwinderman A; Sterk P
    J Asthma; 2016 Dec; 53(10):1026-32. PubMed ID: 27366830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath condensate biomarkers in COPD.
    Borrill ZL; Roy K; Singh D
    Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?
    Slats A; Taube C
    Ther Adv Respir Dis; 2016 Feb; 10(1):57-71. PubMed ID: 26596632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell infiltration discriminates between histopathological phenotypes of chronic obstructive pulmonary disease.
    Ballarin A; Bazzan E; Zenteno RH; Turato G; Baraldo S; Zanovello D; Mutti E; Hogg JC; Saetta M; Cosio MG
    Am J Respir Crit Care Med; 2012 Aug; 186(3):233-9. PubMed ID: 22679009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.
    Subramanian DR; Gupta S; Burggraf D; Vom Silberberg SJ; Heimbeck I; Heiss-Neumann MS; Haeussinger K; Newby C; Hargadon B; Raj V; Singh D; Kolsum U; Hofer TP; Al-Shair K; Luetzen N; Prasse A; Müller-Quernheim J; Benea G; Leprotti S; Boschetto P; Gorecka D; Nowinski A; Oniszh K; Castell WZ; Hagen M; Barta I; Döme B; Strausz J; Greulich T; Vogelmeier C; Koczulla AR; Gut I; Hohlfeld J; Welte T; Lavae-Mokhtari M; Ziegler-Heitbrock L; Brightling C; Parr DG
    Eur Respir J; 2016 Jul; 48(1):92-103. PubMed ID: 27230444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.